期刊文献+

两种国产西罗莫司洗脱支架治疗ST段抬高型心肌梗死患者的疗效和安全性研究 被引量:1

Efficacy and safety of two kinds of homemade sirolimus-eluting stents for treatment of acute ST segment elevation myocardial infarction
原文传递
导出
摘要 目的比较两种国产西罗莫司洗脱支架(Excel与Firebird)对急性ST段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(PCI)的有效性和安全性。方法入选我院急性STEMI患者249例,根据植入支架类型,随机分为Excel支架组136例(54.6%)和Firebird支架组113例(45.4%)。随访6~24个月,平均12个月行定量冠状动脉造影复查。比较两组患者手术即刻成功率,术后住院及随访过程中主要不良心脏事件(包括心原性死亡、再发心肌梗死和靶病变血运重建)发生率及晚期管腔丢失、支架再狭窄、支架内血栓发生率。结果两组患者术前临床基线特征及冠状动脉病变情况、直接PCI术后即刻情况差异均无统计学意义(P〉0.05);术后平均12个月随访中,两组患者死亡分别为2例(1.47%)与1例(0.88%),无心原性死亡。非致死心肌梗死分别为1例(0.74%)与1例(O.88%),靶血管再次血运重建分别为2例(1.47%)与2例(1.77%),差异无统计学意义(均P〉0.05)。定量冠状动脉造影随访两组支架内最小管腔内径、节段内最小管腔内径、支架内晚期管腔丢失、节段内晚期管腔丢失,差异无统计学意义(均P〉0.05);支架内再狭窄、节段内再狭窄、支架内血栓形成的发生率差异亦无统计学意义(均P〉O.05)。结论STEMI患者直接PCI应用两种国产西罗莫司洗脱支架均有效、安全。 Objective To compare the efficacy and safety of two kinds of homemade sirolimus- eluting stents (Firebird and Excel) for treatment of acute ST segment elevation myocardial infarction (STEMI) in patients who underwent percutaneous coronary intervention (PCI). Methods The 249 consecutive patients with STEMI who underwent PCI were randomly divided into two groups: Excel group (n=136) and Firebird group (n=113). They were followed up for 6-24 months, and coronary angiography was reviewed average 12 months later. The primary endpoints were major adverse cardiac events, including death, reinfarction and target vessel revascularization. The second endpoints included late luminal loss and restenosis 12 months after treatment. Results There were no significant differences in baseline data, coronary arterial lesion before operation, and immediateness condition after PCI between the two groups (all P〉0.05). Within follow-up, there were 2 (1.47%) death cases and 1 (0.88%) death case, 1 (0. 74%) and 1 (0. 88%) nonfatal myocardial infarction case, 2 (1.47%) and 2 (1.77%) target vessel revascularization cases in the two groups respectively (all P〉0.05). There were no significant differences in late luminal loss of in-stent and in-segment, the rates of in-stent restenosis, in-segment restenosis and stent thrombosis, the in-stent minimal lumen diameter and in-segment minimal lumen diameter between the two groups (all P〉 0.05).Conclusions The two kinds of homemade sirolimus-eluting stents may have similar efficacy and safety in patients with STEMI treated with primary PCI.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2011年第7期547-550,共4页 Chinese Journal of Geriatrics
基金 上海市浦东新区科技发展基金创新资金项目(PKJ2008-Y12) 上海市浦东新K211生系统重点学科建设资助项目(PWZXK20l005)
关键词 心肌梗死 血管成形术 经腔 经皮冠状动脉 支架 Myocardial infarction Angioplasty, transluminal, percutaneous coronary Stent
  • 相关文献

参考文献10

  • 1金惠根,刘宗军,杨伟,汪蔚青,施佳,王东毅,汪志华,于宏梅,来莺,沈峻,方平.国产西罗莫司洗脱支架与裸支架治疗急性心肌梗死临床疗效的比较[J].中华心血管病杂志,2007,35(8):697-700. 被引量:15
  • 2高海,颜红兵,朱小玲,李南,艾辉,李世英,杨铎,王健,孙晓东,慈维萍.ST段抬高心肌梗死应用国产西罗莫司洗脱支架与金属裸支架的对比研究[J].中国介入心脏病学杂志,2006,14(5):259-262. 被引量:8
  • 3Cutlip DE, Windecker S, Mehran R, et al. Academic Research Consortium. Clinical end points in coronary stent trials : a case for standardized definitions. Circulation, 2007,115:2344-2351.
  • 4Menichelli M, Parma A, Pucci E, et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardid, 2007,49 : 1924-1930.
  • 5De Luca G, Stone GW, Suryapranata H, et al. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction., a meta-analysis of randomized trials. Int J Cardiol, 2009,133:213-222.
  • 6Cura FA,Escudero AG, Berrocal D, et al. Protection of distal embolization in high-risk patients with acute ST-segment elevation myocardial infarction PREMIAR. Am J Cardiol,2007,99:357-363.
  • 7Kahn J. TCT Daily: ESTROFA: late thrombosis not increased in DES patients: Spanish registry of drug-eluting stents shows STEMI, LAD artery lesions, significant risk factors. J Interv Cardiol, 2007,20:32-36.
  • 8Han Y,Jing Q, Xu B, et al. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in" real-world" practice : 18-month clinical and 9-month angiographic outcomes. JACC Cardiovasc Interv, 2009,2:303-309.
  • 9Windecker S,Serruys PW,Wandel S, et al. Biolimus- eluting stent with biodegradable polymer versus sirolimus eluting stent with durable polymer for coronary revascularisation(LEADERS) : a randomised non-inferiority trial. Lancet, 2008,372 : 1163-1173.
  • 10Joner M,Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coil Cardiol, 2006, 48: 193-202.

二级参考文献26

  • 1颜红兵,朱小玲,柯元南,高焱莎,曾玉杰,李宪伦,张坚,郭诗东,柴枝楠.常规开展直接冠状动脉介入治疗的 5年总结[J].中华急诊医学杂志,2005,14(1):64-67. 被引量:18
  • 2Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitiative review of 23 randomised trials. Lancet, 2003,261: 13-20.
  • 3Moses JW, leon MB, Popma JJ, et al. Sirolimus-eluting stents verus standard stents in patients with stenosis in a native coronary arteries.N Engl J Med,2003,349: 1315-1323.
  • 4Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stentt in patients with coronary artery disease. N Engl J Med,2004;350:221-231.
  • 5Lemos PA, Saia F, Hofman SH, et al. Short and long term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardiol infarction. J Am Coil Cardiol, 2004,43: 704-708.
  • 6Hofma SH, van der Giessen WJ, van Dalen BM, et al. Indication of long-term endothelial dysfunction after simlimus-eluting stent implantation. Eur Heart J, 2006,27:166-170.
  • 7Babinska A, Markell MS, Salifu MO, et al. Enhancement of human platelet aggregation and secretion induced by rapamycin. Nephrol Dial Transplant, 1998,13:3153-3159.
  • 8Steffel J, Latini RA, Akhmedov A, et al. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design. Circulation, 2005,112: 2002-2011.
  • 9Guagliumi G, Farb A, Musumeci G, et al. Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. Circulation, 2003, 107: 1340-1341.
  • 10Nebeker JR, Virmani R, Bennet CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coil Cardiol,2006,47:175-181.

共引文献21

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部